Akoya Biosciences Ownership | Who Owns Akoya Biosciences?


OverviewForecastRevenueFinancialsChartTranscripts

Akoya Biosciences Ownership Summary


Akoya Biosciences is owned by 25.32% institutional investors, 72.70% insiders, and 1.99% retail investors. Blue water life science advisors, lp is the largest institutional shareholder, holding 9.46% of AKYA shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.78% of its assets in Akoya Biosciences shares.

AKYA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAkoya Biosciences25.32%72.70%1.99%
SectorHealthcare Stocks 279.42%10.64%-190.05%
IndustryMedical Instruments & Supplies Stocks43.58%14.35%42.08%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blue water life science advisors, lp4.70M9.46%$6.11M
Blackrock1.50M3.05%$3.51M
Vanguard group1.41M2.84%$3.22M
Paragon associates & paragon associates ii joint venture671.00K1.35%$872.30K
Trium capital llp605.50K1.22%$787.14K
Geode capital management565.49K1.14%$1.30M
Blackrock funding, inc. /de499.51K1.01%$649.36K
State street435.83K0.88%$998.05K
Peddock capital advisors234.72K0.47%$305.14K
Northern trust209.72K0.43%$490.74K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Blue water life science advisors, lp4.70M4.83%$6.11M
Paragon associates & paragon associates ii joint venture671.00K1.39%$872.30K
Trium capital llp605.50K0.20%$787.14K
Peddock capital advisors234.72K0.07%$305.14K
Jbf capital119.51K0.02%$155.36K
Css llc/il96.01K0.01%$124.81K
Point72 asia (singapore) pte.19.46K0.00%$25.29K
Transcend capital advisors27.60K0.00%$35.88K
Exoduspoint capital management, lp205.32K0.00%$267.00K
Zwj investment counsel47.98K0.00%$62.37K

Top Buyers

HolderShares% AssetsChange
Trium capital llp605.50K0.20%605.50K
Exoduspoint capital management, lp205.32K0.00%205.32K
Blackrock1.50M0.00%154.35K
Jbf capital119.51K0.02%119.51K
Css llc/il96.01K0.01%96.01K

Top Sellers

HolderShares% AssetsChange
Blackrock funding, inc. /de499.51K--1.11M
Uniplan investment counsel---699.84K
Silvercrest asset management group---580.83K
Parkman healthcare partners---376.13K
Polar capital---329.76K

New Positions

HolderShares% AssetsChangeValue
Trium capital llp605.50K0.20%605.50K$787.14K
Exoduspoint capital management, lp205.32K0.00%205.32K$267.00K
Jbf capital119.51K0.02%119.51K$155.36K
Css llc/il96.01K0.01%96.01K$124.81K
Marshall wace, llp73.88K0.00%73.88K$96.05K

Sold Out

HolderChange
Ifp advisors-1.00
Farther finance advisors-4.00
Sterling capital management-26.00
Redwood wealth management group-30.00
Svb wealth-81.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2025664.76%12,573,9623.62%254.21%29-1946.15%
Dec 31, 2024635.00%12,134,9400.36%244.11%297.41%13-27.78%
Sep 30, 202460-12,091,484-2.37%243.85%27-3.57%18-14.29%
Jun 30, 202460-11.76%12,385,236-16.62%252.25%28-6.67%21-8.70%
Mar 31, 2024683.03%14,854,1210.66%333.68%30-14.29%239.52%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF882.32K1.78%-
Vanguard Total Stock Mkt Idx Inv882.32K1.77%-
Vanguard Institutional Extnd Mkt Idx Tr306.11K0.61%-
Fidelity Small Cap Index264.99K0.53%-
UniSuper Balanced Super175.99K0.35%175.99K
Vanguard Russell 2000 ETF132.34K0.27%1.17K
State St Russell Sm/Mid Cp® Indx NL Cl C123.25K0.25%-
State St Russell Sm/Mid Cp® Indx SL Cl I123.25K0.25%-
Fidelity Extended Market Index121.21K0.24%-316.00
iShares Russell 2000 ETF111.83K0.22%-42.27K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 11, 2024McKelligon Brian President and CEOSell$15.63K
Jun 06, 2024McKelligon Brian President and CEOSell$15.06K
Mar 20, 2024McKelligon Brian President and CEOSell$37.24K
Mar 13, 2024McKelligon Brian President and CEOSell$37.04K
Mar 13, 2024McKelligon Brian President and CEOSell$37.03K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q3--

AKYA Ownership FAQ


Who Owns Akoya Biosciences?

Akoya Biosciences shareholders are primarily institutional investors at 25.32%, followed by 72.70% insiders and 1.98% retail investors. The average institutional ownership in Akoya Biosciences's industry, Medical Instruments & Supplies Stocks, is 43.58%, which Akoya Biosciences falls below.

Who owns the most shares of Akoya Biosciences?

Akoya Biosciences’s largest shareholders are Blue water life science advisors, lp (4.7M shares, 9.46%), Blackrock (1.5M shares, 3.05%), and Vanguard group (1.41M shares, 2.84%). Together, they hold 15.35% of Akoya Biosciences’s total shares outstanding.

Does Blackrock own Akoya Biosciences?

Yes, BlackRock owns 3.05% of Akoya Biosciences, totaling 1.5M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 3.51M$. In the last quarter, BlackRock increased its holdings by 154.35K shares, a 11.45% change.

Who is Akoya Biosciences’s biggest shareholder by percentage of total assets invested?

Blue water life science advisors, lp is Akoya Biosciences’s biggest shareholder by percentage of total assets invested, with 4.83% of its assets in 4.7M Akoya Biosciences shares, valued at 6.11M$.

Who is the top mutual fund holder of Akoya Biosciences shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Akoya Biosciences shares, with 1.78% of its total shares outstanding invested in 882.32K Akoya Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools